Introduction
High-throughput protein expression and purification has a central, pivotal role in structural genomics. In fact, crystallographic-quality protein production on the scale required to generate tens to hundreds of different proteins per day will probably be the greatest obstacle for the conversion of protein structure determination to a high-throughput format. High-throughput efforts in structural biology place unique restrictions on protein expression and purification. First, the majority of gene constructs must be expressed in a synchronous fashion. Second, the purification protocol applied to the majority of expressed proteins must be as similar as possible and produce the very high-quality material that is needed for structural studies. The first requirement can be addressed by employing either large or small N-terminal expression tags, and the second hurdle can be circumvented with the use of affinity purification tags. However, the drawback in incorporating affinity tags in crystallization studies is that in many cases these tags introduce flexible portions to the protein of interest that are not conducive to crystallization or lead to various forms of microheterogeneity. Protease cleavage sites allow removal of these flexible tag regions, but conditions often have to be optimized for each reaction, requiring fine-tuned processing to be incorporated in a high-throughput environment. Given the above caveats on current technology, however, affinity-tag systems are still the most useful to date given the restrictions placed on high-throughput methods.
Several groups and commercial companies are currently designing high-throughput protein production, in particular, systems based on Escherichia coli are described in this review. In addition, other systems are being investigated, including in vitro expression systems [1, 2] , methods that employ baculovirus infection of insect cells with a peptide tag for antipeptide monoclonal antibody purification [3] , and yeast-based expression using a single tag [4] or dual tags [5] . A distinct advantage of in vitro expression systems is the facilitation of selenomethionine (SeMet) incorporation or 15 N labeling. Scale-up has been a problem with this technology, however, and is currently being addressed [1, 2] . Because all of these systems are still in the early stages of development, data collection in a systematic and comprehensive manner will be necessary to arrive at the most efficient and cost-effective solution for high-throughput protein expression and purification.
The parallel production of protein targets, expressed under a range of conditions with a variety of affinity tags, will result in a number of successful conditions for protein production, along with many unsuccessful conditions. By analyzing which conditions produce viable samples for a given type of protein and which conditions do not work, a large knowledge base will be produced. This knowledge base will provide the foundation for a statistically relevant method of predicting effective expression conditions for protein samples with similar physical and biochemical properties. As this knowledge base grows in volume, the predictive power should improve, resulting in a larger number of successes and an exponential growth of the knowledge base itself. Through this iterative process, trends in protein production will become apparent, and the speed and efficiency of high-throughput protein production will be greatly enhanced. Each aspect from cloning to protein quality control is discussed here with an emphasis towards high-throughput methods and collection of success/failure data in a systematic manner.
Cloning
Recombinant protein yield and solubility are highly dependent on the specific protein sequence, as well as on the vector, host cell, and culture conditions used. For optimal efficiency, various combinations should be simultaneously screened to determine the conditions that yield the 'best' protein, for example, choosing five different expression clones for each protein of interest (see Figure 1 ). Cloning using restriction enzymes typically cannot be used for high-throughput approaches, owing to the complication of selecting compatible and appropriate restriction enzymes for each cloning procedure. Additionally, multiple steps of experimental refinement and treatment must be performed using the restriction enzyme(s) of interest. High-throughput cloning therefore requires procedures based on the polymerase chain reaction (PCR). A first step involves the design of specific gene PCR amplification primers, followed by screening of potential PCR-amplified clones for proper insert orientation. Sequence analysis of positive clones must be performed, to confirm that a proper reading frame has been obtained and that no PCR-introduced errors are present. This step is followed by a final archiving of selected plasmid DNA samples. Automated systems are available for colony picking, gridding, and microarraying (e.g. the 'Q Pix' system sold by Genetix [http://www.genetix.co.uk] and the Gene Suite™ available from GeneMachines [http://www.genemachines.com]) and also for sequencing (e.g. fluorescence-based systems available from Perkin Elmer Biosystems, Amersham Pharmacia Biotech, and Visible Genetics).
To generate expression vector clones, cloning systems such as the Invitrogen Echo™ system [6] , the Gibco/Life Technologies Gateway™ system, or the Novagen pTriEx-1 cloning system [7] may be advantageous. These generic processes streamline the expression cloning process by alleviating costly, time-consuming recloning steps and avoiding the use of restriction enzymes in the cloning and subcloning process. For example, the Invitrogen system inserts the PCR-amplified gene fragment into a TOPO™ 'donor' vector using a topoisomerase-I-adapted plasmid. CRE recombinase is then used in a second step to introduce the correct cloned sequence into a loxP-adapted recipient vector (E. coli, insect, yeast, and mammalian choices are all available) for subsequent protein expression studies.
Expression
High-throughput approaches will rely upon both prokaryotic and eukaryotic hosts. Bacterial expression systems are advantageous for a variety of reasons, most notably that protein overexpression is usually obtained without any post-translational modification heterogeneity. In addition, E. coli protein expression is cheaper and faster than eukaryotic systems. In comparison, more expensive and slower eukaryotic systems will be necessary for the expression of some subsets of proteins, especially those that require post-translational modifications for proper folding and activity. Currently, many companies have available a variety of vector/host expression systems (see the Supplementary material section). Numerous heterologous gene expression systems are available (see the Supplementary material section), and additional variants can be constructed using combinations of strong promoters and tight regulators (as listed in Table 1 ) along with the proper transcription initiation and translation signals. These systems produce recombinant gene products in an efficient and regulatable manner [8, 9] . Cost-effective E. coli expression, using T7 RNA polymerase plus the T7 promoter [10, 11] with induction for high-yield recombinant protein overexpression, appears to be appropriate for 'first pass' efforts.
As previously mentioned, there is an important advantage in using tags in high-throughput protein expression and purification efforts, so that all proteins will have a generic 'handle'. Several N-terminal expression tags are available (see Table 2 ), ranging from large tags (e.g. E. coli thioredoxin [12] , Schistosoma japonicum glutathione-S-transferase [GST] [13] and E. coli maltose-binding protein [MBP] [14] ) down to fairly small tags (e.g. S-tag [15] , His-tag [16] and T7-tag) [17] [18] [19] [20] [21] [22] [23] . Although expression data and correlation to crystallization have not been conducted in a thorough manner, it is generally believed that the expression fusion tags need to be removed, particularly for large fusion partners. Table 3 summarizes the possible choices for incorporating tag-cleavage and self-cleavage into expression constructs. Unfortunately, the endopeptidases suffer from many limitations, including the presence of peptide secondary cleavage site activity (leading to proteolytically damaged products), incomplete sample cleavage (leading to product heterogeneity which hampers crystallization), and inhibition of cleavage by properly folded proteins (requiring partial denaturation for successful fusion-tail cleavage) [24] . The viral proteases to date have proven to be the most selective and useful for structural biology studies. There is the additional possibility of utilizing Overview of the steps involved in high-throughput protein production for structural studies. With the correct positive and negative controls, one should be able to pass through such a flowchart only once in order to successfully obtain protein samples suitable for structural analysis. The numbers indicate preferences in the flowchart diagram. 
Optimizing expression levels
High-throughput expression requires the parallel induction of all clones in one expression run under the same conditions, which requires the presence of N-terminal expression tags to standardize baseline recombinant protein expression levels. In order to enable reliable prediction of expression constructs that generate soluble or insoluble expressed proteins, empirical trials need to be performed, altering expression conditions (e.g. the temperature or inducer concentration used for a run) and observing the solubilities and stabilities of the recombinant proteins, that are obtained [28] . As outlined in Figure 1 , a probable combination of five different conditions should be probed. Prescreening using SDS-PAGE, in combination with Western blot analysis, is advantageous to analyze expression constructs on a smallscale and to determine the levels of proteins produced. This screening also provides information on the degradation or aggregation of proteins from potential expression clones.
Host strain genotype is important for obtaining optimal expression levels, and many specialized E. coli strains have been developed. For example, the BL21 lon and ompT protease-deficient strain improves the likelihood of isolating intact full-length recombinant proteins [10] . Another important variable is the induction level used [29] . Although high-level expression can usually be obtained, optimizing the yield of properly folded protein might require a reduction in the induction level. Finally, media formulations must be considered. In some instances, optimal expression might require supplementary salts (e.g. Zn 2+ , Cu 2+ , Ca 2+ , Fe 2+ , Fe 3+ ) and potential cofactors or prosthetic groups (e.g. heme, FAD, FMN, tetrahydrobiopterin) to be included [30] ; for example, for proteins with catalytically or structurally important metal centers expression trials should contain metal ions in the culture media [31, 32] . Studies should determine optimal media formulations for maximal recombinant protein yield; for example, with rich media formulations more active proteins are sometimes produced [33] . Current media conditions are old and outdated, and were developed for different applications. There is a need to develop new media conditions optimized for high-expression level protein production under highdensity growth conditions.
Purification
Recombinant protein purification is facilitated by the use of high-yield expression systems so that the desired protein is produced in an enriched form. Purification is further simplified by the presence of affinity purification tags. For high-throughput processing, initial efforts have focused on soluble and insoluble purification strategies using the cost-effective His-tag [34] . The incorporation of a His-tag allows for a generic single-step purification using nickel-nitrilotriacetate or other immobilized metal-affinity chromatography resins. In practice, a second purification step is almost always required, using either ion-exchange or size-exclusion chromatography. Equipment originally designed for high-throughput DNA manipulations, such as 96-well robotics manifolds, are available for parallel protein sample purification from Qiagen (http://www.qiagen.com).
A final factor to consider, once purified proteins are obtained, is that protein samples for structural studies must be of fairly high concentration, although the range varies from 1 mg/ml to greater than 60 mg/ml (average values are 10-15 mg/ml). Because all proteins vary in their tendency to aggregate and precipitate from solution, it is impossible to define one specific concentration or buffer condition for all protein targets. However, the rules for
Ways & Means High-throughput protein production methods Stevens R179 approximating the required concentration are relatively simple. First, the protein concentration should be in a range such that crystallization factorial conditions will allow the protein to reach the solution solubility limit. Second, there must be sufficient protein present in an aliquoted droplet to generate a crystal large enough for X-ray diffraction analysis. For example, a 40 nl droplet can maximally produce a single protein crystal 50 µm in size, assuming a 50% solvent content in the crystal and a starting protein concentration of 10 mg/ml. Hence, a proteinconcentrating step must normally be used in protein purifications for crystallization studies. Ion-exchange chromatography has proven useful as a second 'polishing' purification step, as well as directly yielding concentrated solutions upon column elution.
The use of inclusion bodies and refolding screens
Many heterologous proteins that are overexpressed lead to the formation of insoluble protein aggregates known as inclusion bodies [23, 30] . Current estimates are that 15-20% of human gene constructs expressed in E. coli are soluble, 20-40% form as inclusion bodies, and the remainder do not express significantly or are degraded. Inclusion-body formation can be minimized, or potentially avoided, by adopting a combinatorial approach towards the expression of soluble recombinant protein [10, 35, 36] . Several modifications in expression conditions should be incorporated into in vivo refolding screens to attempt to minimize unfavorable solution behavior: screening for the best host/expression construct combinations; induction at lower temperatures [37, 38] ; lowering the concentration of inducing agent; altering the media composition (e.g. adding sucrose or polyols [39] ); co-expressing chaperones and other in vivo folding enhancers [40] [41] [42] [43] [44] [45] ; expressing the protein as a fusion with a 'solubilizing partner' such as GST, MBP, thioredoxin [46] or NusA [47, 48] . In addition, periplasmic secretion can influence recombinant protein solubility [49] [50] [51] [52] , making leader sequence tags a consideration for high-throughput
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Growth hormone, N terminus recombinant protein expression trials. Finally, an initial report on developing a mutation screen for soluble protein using green fluorescent protein (GFP) chimeric fusions has been proposed [53] .
Inclusion-body-derived proteins can be advantageous for high-throughput methods. They are produced in high yields, and are generally protected from proteolytic degradation. Properly folded proteins can be produced from these intractable inclusion bodies using a variety of solubilization and refolding schemes [43, [54] [55] [56] [57] [58] [59] [60] [61] [62] . The use of inclusion-body routes is especially attractive for the production of proteins that are toxic to host cells. Unfortunately, high-throughput refolding screens must still be developed, especially as different proteins have highly variable refolding efficiencies [20] . In addition, partial success at in vitro refolding has been obtained with hydrophobic interaction chromatography [23, 63] , but this method has only been marginally tested. Recently, a factorial refolding screen was reported by Gouaux and coworkers [64] , but their current system requires an activity assay to assess the success of the refolding procedure. Their system can easily be modified to monitor the success of refolding using fluorescence or circular dichroism spectroscopy [43] . One attractive format for querying protein solubility behavior uses a microdrop screening method to optimize solvent conditions for nuclear magnetic resonance (NMR) spectroscopy of proteins [65] ; this methodology might be used to develop high-throughput refolding screens. Unfortunately, current refolding screens are of the hit-and-miss variety [24] . Current methods do not provide rational refolding pathways, allowing for the formation of complex mixtures when attempts are made to renature completely denatured polypeptide chains into properly folded proteins. During generic refolding processes, severe heterogeneity problems can arise owing to the formation of multiple refolded species and aggregates. Hence, efforts aimed at recombinant protein refolding should probe as many factors as possible to maximize the probability of obtaining properly folded native conformation protein.
Quality assessment
Protein crystal growth requires stringent protein purity. Samples must be pure in terms of lacking contaminants, but must also be relatively monodisperse [66] , homogeneous, and 'conformationally pure', lacking denatured species and other structural microheterogeneities that adversely affect crystal growth [67] [68] [69] . Microheterogeneities, such as variations in primary, secondary, tertiary, and quarternary structure, as well as the presence of various aggregation states, also affect purification and crystallization properties. Every protein is unique in terms of physical properties such as hydrophobic content, surface charge, and solubility behavior with the addition of precipitants, making the propensity of each protein to crystallize very protein-specific. Some proteins can crystallize with impurities or microheterogeneities present, whereas others cannot. It is generally accepted, however, that for ease in crystallization one should have a protein that is as pure and homogeneous as possible.
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Excision site ( ↓ ) Cleavage enzyme/self-cleavage Comments
Asp-Asp-Asp-Asp-Lys ↓ Enterokinase The site will not cleave if followed by a proline residue. Secondary cleavage sites at other basic residues, depending on conformation of protein substrate. Active from pH 4.5 to 9.5 and between 4°C and 45°C [24] .
Ile-Glu/Asp-Gly-Arg ↓ Factor Xa protease Will not cleave if followed by proline and arginine. Secondary cleavage sites following Gly-Arg sequences.
Leu-Val-Pro-Arg ↓ Gly − Ser Thrombin Secondary cleavage sites. Biotinylated form available for removal with immobilized streptavidin.
Glu-Asn-Leu-Tyr-Phe-Gln ↓ Gly TEV protease Seven-residue recognition site, making it a highly site-specific protease.
Active over a wide range of temperatures. Protease available as a His-tag fusion protein, allowing for protease removal after recombinant protein cleavage.
Leu-Glu-Val-Leu-Phe-Gln ↓ Gly-Pro PreScission TM protease Genetically engineered form of human rhinovirus 3C protease with a GST fusion tag, allowing for facile cleavage and purification of GST-tagged proteins along with protease removal after recombinant protein cleavage. Enables low-temperature cleavage of fusion proteins containing the eightresidue recognition sequence. Prior to the performance of crystallization trials, the purity and homogeneity of protein samples must be confirmed. Automated high-throughput SDS-PAGE and matrix-assisted laser desorption ionization (MALDI) mass spectrometry [70, 71] can be used for purity assessment, with dynamic light scattering measurements [66, [72] [73] [74] used to verify sample dispersity and the degree of aggregation. Sampling miniaturization issues are already being addressed, for example, high-throughput MALDI mass spectroscopy [75] and automated 96-well format bioanalysis procedures [76, 77] are being developed in recent proteomics efforts.
The ability to screen and analyze results for numerous crystallization trials will allow the correlation of the above measured properties as a function of the processing variables, allowing for improvements in future protein production efforts.
Conclusions
A tremendous number of anecdotal stories exist regarding successes and failures of protein expression, purification, and crystallization of macromolecules. For example, the influence of affinity tags on recombinant protein structure and stability, and the use of additives in media growth have been much debated. This type of information in the Protein Data Bank is not complete. Most expression studies are not performed in a systematic fashion, and failure data is rarely reported. These deficiencies require that further cataloguing and characterization of the influence of different process variables be included in highthroughput purification procedures.
Numerous attractive possibilities currently exist for highthroughput protein production efforts. Current attempts focus on systematic methods for manipulating and processing expressed clones in parallel. It is naive, however, to believe that one simple, global solution will be possible. It will be important to approach the development of highthroughput protein production efforts from a 'learning system' viewpoint. Systematic studies will lay the groundwork for the assembly of comprehensive information databases that can then be used to refine the procedures necessary for efficient genome-scale protein expression and purification efforts [78] . Experience gained will guide later efforts and will assist in solving problems identified in the first rounds of protein production. Finally the problems encountered in the production of more difficult protein targets, such as integral and membrane-associated proteins, still need to be addressed [79] .
Supplementary material
Supplementary material including the URLs for several companies that produce high-throughput expression systems is available at http://current-biology.com/supmat/supmatin.htm.
